-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - dosing,
application of dose thresholds), concomitant therapies (e.g.,
use of benzodiazepines or other drugs … Strategy (REMS) a single shared system
- Current Application Holders. http://www.fda.gov/
downloads/Drugs … Available at:http://www.fda.gov/Drugs/DrugSafety/
PostmarketDrugSafetyInformationforPatientsandProviders
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-updates_methods.pdf
July 01, 2011 - evidence-based-policy-
center/derp/index.cfm), has conducted SRs of comparative effectiveness and safety for drugs … then key questions for potential modifications are assessed to accommodate
new evidence (e.g., new drugs … These
developments include new controversies, drugs or devices in development, ongoing trials and … across EPCs
across the range of health care interventions and treatment modalities (e.g., devices,
pharmaceutical … products, surgery, diagnostic tests, and other procedures) is needed.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
February 01, 2012 - For
the majority of antipsychotic drugs, approved indications in the United States are restricted to … and becomes notably more resource intensive for
the comparison of three or more drugs. … Second-
generation versus first-generation
antipsychotic drugs for schizophrenia: a
meta-analysis. … Antipsychotic drugs and extrapyramidal side
effects in first episode psychosis: a systematic
review … None named Novartis
Pharmaceuticals
NCT01256177 Evaluate the Efficacy and Safety of Quetiapine Fumarate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_consumer.pdf
August 01, 2015 - � Chemotherapy: Certain drugs are used to kill cancer cells.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
August 01, 2020 - for the same drug, while Table 5b summarizes retention findings for XR and daily formulations
for drugs … vulnerability assessment
for rapid dissemination of HIV or HCV
infections among persons who inject drugs … KQ3: Not reported
Fair
Rosenthal,
201634
RCT
USA
Braeburn
Pharmaceuticals
177
Age … Medications Timing & Outcome Interventions Results Quality
Rating
Lofwall, 201835
RCT
USA
Braeburn
Pharmaceuticals
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
August 06, 2018 - Pharmacological agents used to treat child and adolescent depression
Class Drugs
Selective serotonin … Tricyclic drugs for depression in children and adolescents. … 7-25-18
1st addendum database - CINAHL done 7-27-18
2nd addendum in all indexes for rarely used drugs … antidepressive
agents”[Title/Abstract] OR “antidepressive drug”[Title/Abstract] OR
“antidepressive drugs … OR “antidepressive agent” OR
“antidepressive agents” OR “antidepressive drug” OR
“antidepressive drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … at Point of This Intervention
Patients with OA are often prescribed nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
March 01, 2013 - combined functional outcomes measured on different
scales in placebo-controlled studies of Alzheimer’s drugs … and large referents,34 the clinical
significance of the additional treatment effect of Alzheimer’s drugs … Enhanced persistence with
tiotropium compared with other respiratory
drugs in COPD. … Drugs Aging.
2007;24:155-67.
34. Cohen J.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
January 01, 2007 - Survey of Medicare Part D Plans’ Medication Therapy Management Programs
Effective Health Care
Research Reports
Number 1
Survey of Medicare Part D Plans’
Medication Therapy Management Programs
Daniel R. Touchette, Pharm.D., M.A.
Anne L. Burns, R.Ph.
Marcie A. Bough, Pharm.D.
Juan C. Blackburn, M.D., M.B.…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
October 07, 2011 - the Food and Drug Administration and as
described in the prescribing information for the above cited drugs … Prescribing information for these drugs may be obtained from
www.astrazeneca-us.com or by calling the … Recommend the following language:
“When used in pregnancy during the second and third trimesters,
drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
October 01, 2018 - Formulary Committee Neurology and
Psychiatry Task Force, responsible for making decisions on which drugs … therapy (specifically, they were
asked to simulate a decision in which they are trying to choose which drugs … Explicit description of the intervention (dosing, duration, delivery,
manpower, trade names of drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
January 28, 2019 - analgesics, including ketamine, nitrous oxide/oxygen, acetaminophen, and non-steroidal
anti-inflammatory drugs … prehospital analgesia, issues pertaining to
emergency medical services (EMS) personnel who administer the drugs … Abbreviations: KQ=key question; NSAIDs=nonsteroidal anti-inflammatory drugs; PICOTS=population,
intervention
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer
Evidence-based Practice Center Systematic Review Protocol
Project Title: Therapies for Clinically Localized Prostate Cancer
Initial Publication Date: September 12, 2019
Amendment Date: November 2,…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
January 01, 2018 - Public Reviewer #4
(Manisha Madhoo,
Shire
Pharmaceuticals)
(Previous row
continued)
Methods • … CNS Drugs. 2013 Dec;27(12):1081-92. … Public Reviewer #4
(Manisha Madhoo,
Shire
Pharmaceuticals)
Methods Lastly, the authors may want … TEP Reviewer #2 Discussion/
Conclusion
[conclusion that for ADHD treatment, FDA-approved drugs
most … Yet the conclusions make clear recommendation
that "For ADHD treatment, FDA-approved drugs are most
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … It
differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
October 01, 2017 - These reviews focus on a variety of issues, including assessing and comparing clinical
drugs, treatments … I feel like the thing that I'm most struggling with from an evidence-based standpoint, is
limiting pharmaceuticals … o What are the opportunities to substitute less costly, but equally effective,
pharmaceuticals for specific … These reviews
focus on a variety of issues, including comparing clinical drugs or treatments, and interventions … o Prevention strategies
o Diagnostic strategies
o Treatment strategies
Drugs, devices, non-pharmaceuticals
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
March 01, 2012 - For drugs like etidronate and
sodium fluoride that could produce abnormal bone
(osteomalacia) fracture … Based on a new RCT, we have added Teriparatide to the
conclusion about drugs that effectively prevent … Yet these
drugs are not included in the efficacy section. Delete. … These drugs have been omitted from the evidence table as they
were deleted from the report. … A review of studies examining the characteristics of the drugs
was beyond the scope of this project.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
January 01, 2007 - conduct and support research on the comparative
outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … currently used interventions, including angioplasty
with stent placement and/or those antihypertensive drugs … explicitly evaluated aggressive medical treatment with ACE
inhibitors, statins, and anti-platelet drugs … after
revascularization do occur in a small percentage of patients, and each of the
antihypertensive drugs … eligibility criteria reported analyses of whether
periprocedural interventions, such as different drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
January 01, 2009 - Medicare Parts A, B, and D Beneficiaries With Hypertension, With Use of One or More Antihypertensive Drugs … , With
Hypertension and Use of One or More Antihypertensive Drugs, and Average Number of Antihypertensive … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use
of One or More Antihypretensive Drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
January 01, 2013 - Disease-Modifying Antirheumatic Drugs
(DMARDs) in Children With Juvenile
Idiopathic Arthritis (JIA) … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … Disease-Modifying Antirheumatic Drugs
(DMARDs) in Children With Juvenile
Idiopathic Arthritis (JIA) … PICO
(Intervention):
Corticosteroids;
Synthetic disease-
modifying anti-
rheumatic drugs
(DMARDs)